000			01930 a2200553 4500
005			20250516174012.0
264		0	_c20140328
008			201403s 0 0 hun d
022			_a0030-6002
024	7		_a10.1556/OH.2013.29726 _2doi
040			_aNLM _beng _cNLM
100	1		_aIványi, János László
245	0	0	_a[Treatment outcome in primary testicular non-Hodgkin lymphoma]. _h[electronic resource]
260			_bOrvosi hetilap _cOct 2013
300			_a1666-73 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBurkitt Lymphoma _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aHungary _xepidemiology
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdrug therapy
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aOrchiectomy
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRetrospective Studies
650	0	4	_aRituximab
650	0	4	_aTesticular Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xadministration & dosage
700	1		_aMarton, Eva
700	1		_aPlander, Márk
700	1		_aEngert, Zoltán Vendel
700	1		_aTóth, Csaba
773	0		_tOrvosi hetilap _gvol. 154 _gno. 42 _gp. 1666-73
856	4	0	_uhttps://doi.org/10.1556/OH.2013.29726 _zAvailable from publisher's website
999			_c23166976 _d23166976